ADO

0.00%

2.7¢ anteotech ltd

New TGA guidlines for RATs, page-103

First 103 Last

Share
Profile

Follow
Buckland

8,968 Posts.

1750

04/02/22

12:53

Post #: 59356709
Share

Originally posted by FlippinPhil: ↑

I must say I am tiring of the impatience of people on here in regards to commercialisation.
The company has transformed from a component supplier to a an OEM equipment manufacturer in a very short time frame for the industry.
As I have previously said, Phillips spent 6 years and millions and millions of dollars getting their product to work only to abandon it in the end.
We have reportedly one of the best performing tests IN THE WORLD, and are awaiting regulatory approvals for a very new area for Australia.
The company has gone from around 14 staff 2 years ago to approx 50 now, and am sure they aren’t sitting around waiting for the TGA.
This is approx 1 new staff member per month that needs to be advertised for, interviewed, create job descriptions, get trained etc, which is no small feat.
We have brought in new industry experts on advisory panels.
The company has a near term pathway to commence a decent size production facility with plans to rapidly expand towards the end of this year.
They have rented a 2500 Sqm (from memory) facility nearby to house extra staff and the production equipment.
My guesstimate is they have a lot of spare space to house many more machines to produce tests.
On top of all this, they are dealing with some of the largest battery manufacturers in the world with what seems to be a truly disruptive tech.
On top of all that the share price has risen over 10 times in that same time.
Patience is a hard thing to learn, but after holding for nearly 26 years I think a few more months isn’t much to ask.
The company is closer than ever before to a transformation period, so I am asking fellow holders to take a deep breath and stop with the company and board bashing.
I think it’s a case of 50 ducks paddling, with nothing going on above water, but they are paddling their hearts out below.
An oldie for BigE. “It won’t happen overnight, but it will happen”

Expand

No income and additional staff costs must be covered regather by sales or shareholders so why wouldn't shareholders be wanting to see commercialisation.
Currently it appears that ADO could be missing out on millions of dollars by not having TGA approval

ADO Price at posting: 22.0¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

IMU

Imugene kicks off Australian trial for blood cancer treatment

HotCopper Highlights: Your most watched and most discussed stocks this week

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Trump is President Again: What Does This Mean for Crypto?

First 103 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.7¢		Change 0.000(0.00%)		Mkt cap ! $67.22M

Open	High	Low	Value	Volume
2.7¢	2.9¢	2.7¢	$17.68K	634.1K

Buyers (Bids)

No.	Vol.	Price($)
7	541015	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	4693635	4

View Market Depth

No.	Vol.	Price($)
6	537498	0.027
7	653551	0.026
13	1982099	0.025
7	2179250	0.024
4	1110217	0.023

Price($)	Vol.	No.
0.029	4693635	4
0.030	359200	3
0.031	75000	1
0.032	191382	2
0.034	428717	4

Last trade - 16.10pm 08/11/2024 (20 minute delay)

ADO (ASX) Chart

New TGA guidlines for RATs, page-103

Imugene kicks off Australian trial for blood cancer treatment

HotCopper Highlights: Your most watched and most discussed stocks this week

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

Universal Biosensors flat despite fresh deal with US medical product distributor

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Flynn Gold reaches milestone exploration target for Golden Ridge

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Trump is President Again: What Does This Mean for Crypto?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

New TGA guidlines for RATs, page-103

Top Stories

Imugene kicks off Australian trial for blood cancer treatment

HotCopper Highlights: Your most watched and most discussed stocks this week

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

Universal Biosensors flat despite fresh deal with US medical product distributor

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Flynn Gold reaches milestone exploration target for Golden Ridge

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Trump is President Again: What Does This Mean for Crypto?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News